410 related articles for article (PubMed ID: 17689568)
21. Cross-platform toxicogenomics for the prediction of non-genotoxic hepatocarcinogenesis in rat.
Römer M; Eichner J; Metzger U; Templin MF; Plummer S; Ellinger-Ziegelbauer H; Zell A
PLoS One; 2014; 9(5):e97640. PubMed ID: 24830643
[TBL] [Abstract][Full Text] [Related]
22. Failure of the standard battery of short-term tests in detecting some rodent and human genotoxic carcinogens.
Brambilla G; Martelli A
Toxicology; 2004 Mar; 196(1-2):1-19. PubMed ID: 15036752
[TBL] [Abstract][Full Text] [Related]
23. Short-term tests for defining mutagenic carcinogens.
Waters MD; Stack HF; Jackson MA
IARC Sci Publ; 1999; (146):499-536. PubMed ID: 10353401
[TBL] [Abstract][Full Text] [Related]
24. Toxicogenomics applied to in vitro carcinogenicity testing with Balb/c 3T3 cells revealed a gene signature predictive of chemical carcinogens.
Rohrbeck A; Salinas G; Maaser K; Linge J; Salovaara S; Corvi R; Borlak J
Toxicol Sci; 2010 Nov; 118(1):31-41. PubMed ID: 20713471
[TBL] [Abstract][Full Text] [Related]
25. Prediction of nephrotoxicant action and identification of candidate toxicity-related biomarkers.
Thukral SK; Nordone PJ; Hu R; Sullivan L; Galambos E; Fitzpatrick VD; Healy L; Bass MB; Cosenza ME; Afshari CA
Toxicol Pathol; 2005; 33(3):343-55. PubMed ID: 15805072
[TBL] [Abstract][Full Text] [Related]
26. Differences in gene expression profiles in the liver between carcinogenic and non-carcinogenic isomers of compounds given to rats in a 28-day repeat-dose toxicity study.
Nakayama K; Kawano Y; Kawakami Y; Moriwaki N; Sekijima M; Otsuka M; Yakabe Y; Miyaura H; Saito K; Sumida K; Shirai T
Toxicol Appl Pharmacol; 2006 Dec; 217(3):299-307. PubMed ID: 17070881
[TBL] [Abstract][Full Text] [Related]
27. Prediction of rodent carcinogenic potential of naturally occurring chemicals in the human diet using high-throughput QSAR predictive modeling.
Valerio LG; Arvidson KB; Chanderbhan RF; Contrera JF
Toxicol Appl Pharmacol; 2007 Jul; 222(1):1-16. PubMed ID: 17482223
[TBL] [Abstract][Full Text] [Related]
28. Carcinogenicity categorization of chemicals-new aspects to be considered in a European perspective.
Bolt HM; Foth H; Hengstler JG; Degen GH
Toxicol Lett; 2004 Jun; 151(1):29-41. PubMed ID: 15177638
[TBL] [Abstract][Full Text] [Related]
29. Differential gene expression profiling between genotoxic and non-genotoxic hepatocarcinogens in young rat liver determined by quantitative real-time PCR and principal component analysis.
Suenaga K; Takasawa H; Watanabe T; Wako Y; Suzuki T; Hamada S; Furihata C
Mutat Res; 2013 Feb; 751(1):73-83. PubMed ID: 23183053
[TBL] [Abstract][Full Text] [Related]
30. Mouse-specific carcinogens: an assessment of hazard and significance for validation of short-term carcinogenicity bioassays in transgenic mice.
Battershill JM; Fielder RJ
Hum Exp Toxicol; 1998 Apr; 17(4):193-205. PubMed ID: 9617631
[TBL] [Abstract][Full Text] [Related]
31. Identification of specific mRNA signatures as fingerprints for carcinogenesis in mice induced by genotoxic and nongenotoxic hepatocarcinogens.
Kossler N; Matheis KA; Ostenfeldt N; Bach Toft D; Dhalluin S; Deschl U; Kalkuhl A
Toxicol Sci; 2015 Feb; 143(2):277-95. PubMed ID: 25410580
[TBL] [Abstract][Full Text] [Related]
32. Discrimination of genotoxic and non-genotoxic hepatocarcinogens by statistical analysis based on gene expression profiling in the mouse liver as determined by quantitative real-time PCR.
Watanabe T; Suzuki T; Natsume M; Nakajima M; Narumi K; Hamada S; Sakuma T; Koeda A; Oshida K; Miyamoto Y; Maeda A; Hirayama M; Sanada H; Honda H; Ohyama W; Okada E; Fujiishi Y; Sutou S; Tadakuma A; Ishikawa Y; Kido M; Minamiguchi R; Hanahara I; Furihata C
Mutat Res; 2012 Sep; 747(2):164-75. PubMed ID: 22634710
[TBL] [Abstract][Full Text] [Related]
33. [The relation between carcinogenesis and mutagenesis: a re-evaluation].
Bartsch H; Malaveille C
Bull Acad Natl Med; 1989 Nov; 173(8):1005-12; discussion 1013-5. PubMed ID: 2633853
[TBL] [Abstract][Full Text] [Related]
34. In vivo murine hepatic microRNA and mRNA expression signatures predicting the (non-)genotoxic carcinogenic potential of chemicals.
Melis JP; Derks KW; Pronk TE; Wackers P; Schaap MM; Zwart E; van Ijcken WF; Jonker MJ; Breit TM; Pothof J; van Steeg H; Luijten M
Arch Toxicol; 2014 Apr; 88(4):1023-34. PubMed ID: 24390151
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of the Vitotox and RadarScreen assays for the rapid assessment of genotoxicity in the early research phase of drug development.
Westerink WM; Stevenson JC; Lauwers A; Griffioen G; Horbach GJ; Schoonen WG
Mutat Res; 2009 May; 676(1-2):113-30. PubMed ID: 19393335
[TBL] [Abstract][Full Text] [Related]
36. Screening assays for carcinogenic agents and mixtures: an appraisal based on data in the IARC Monograph series.
Bartsch H; Malaveille C
IARC Sci Publ; 1990; (104):65-74. PubMed ID: 2228144
[TBL] [Abstract][Full Text] [Related]
37. Predicting the hepatocarcinogenic potential of alkenylbenzene flavoring agents using toxicogenomics and machine learning.
Auerbach SS; Shah RR; Mav D; Smith CS; Walker NJ; Vallant MK; Boorman GA; Irwin RD
Toxicol Appl Pharmacol; 2010 Mar; 243(3):300-14. PubMed ID: 20004213
[TBL] [Abstract][Full Text] [Related]
38. A toxicogenomic approach for the prediction of murine hepatocarcinogenesis using ensemble feature selection.
Eichner J; Kossler N; Wrzodek C; Kalkuhl A; Bach Toft D; Ostenfeldt N; Richard V; Zell A
PLoS One; 2013; 8(9):e73938. PubMed ID: 24040119
[TBL] [Abstract][Full Text] [Related]
39. Exploiting microRNA and mRNA profiles generated in vitro from carcinogen-exposed primary mouse hepatocytes for predicting in vivo genotoxicity and carcinogenicity.
Rieswijk L; Brauers KJ; Coonen ML; Jennen DG; van Breda SG; Kleinjans JC
Mutagenesis; 2016 Sep; 31(5):603-15. PubMed ID: 27338304
[TBL] [Abstract][Full Text] [Related]
40. [Genotoxicity of carcinogenic substances in humans and animals].
Malaveille C; Bartsch H
J Toxicol Clin Exp; 1989; 9(2 Pt 2):15-25. PubMed ID: 2677321
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
